Literature DB >> 15804436

Selective potentiation of opioid analgesia by nonsteroidal anti-inflammatory drugs.

Shayna Zelcer1, Yuri Kolesnikov, Ivanka Kovalyshyn, David A Pasternak, Gavril W Pasternak.   

Abstract

Opioids are often used in conjunction with nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of moderate to severe pain. In this study we have examined interactions between these two classes of drugs. NSAIDs are inactive in the radiant heat tail-flick test, an assay of moderate to severe pain in which opioids are effective. In this assay, ibuprofen potentiated the analgesic actions of hydrocodone and oxycodone, shifting their ED(50) values by 2.5-fold and 4.6-fold despite its inactivity when given alone. These opioid/NSAID interactions were dependent upon both the opioid and the NSAID. Neither aspirin nor ketorolac influenced hydrocodone actions in this model and ibuprofen did not potentiate fentanyl or morphine analgesia. Together, these studies demonstrate potent interactions between selected combinations of opioids and NSAIDS and may help explain the clinical utility of combinations. However, the findings also illustrate differences between the drugs within each class.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804436     DOI: 10.1016/j.brainres.2005.01.070

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

Review 1.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

Review 2.  Preclinical pharmacology and opioid combinations.

Authors:  Gavril W Pasternak
Journal:  Pain Med       Date:  2012-03       Impact factor: 3.750

3.  Topical methadone and meperidine analgesic synergy in the mouse.

Authors:  Yuri A Kolesnikov; Galina Oksman; Gavril W Pasternak
Journal:  Eur J Pharmacol       Date:  2010-04-28       Impact factor: 4.432

Review 4.  Oxycodone combinations for pain relief.

Authors:  R B Raffa; J V Pergolizzi; D J Segarnick; R J Tallarida
Journal:  Drugs Today (Barc)       Date:  2010-06       Impact factor: 2.245

Review 5.  The "Culture" of Pain Control: A Review of Opioid-Induced Dysbiosis (OID) in Antinociceptive Tolerance.

Authors:  Ryan A Mischel; Karan H Muchhala; William L Dewey; Hamid I Akbarali
Journal:  J Pain       Date:  2019-12-11       Impact factor: 5.820

Review 6.  Placebo Analgesia in Rodents: Current and Future Research.

Authors:  Asaf Keller; Titilola Akintola; Luana Colloca
Journal:  Int Rev Neurobiol       Date:  2018-03-07       Impact factor: 3.230

Review 7.  Oxycodone/Ibuprofen combination tablet: a review of its use in the management of acute pain.

Authors:  Vicki Oldfield; Caroline M Perry
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  Effect of ciprofloxacin and ibuprofen on the in vitro metabolism of rosiglitazone and oral pharmacokinetics of rosiglitazone in healthy human volunteers.

Authors:  J N Suresh Kumar; Prameela Devi; Lakshmi Narasu; Ramesh Mullangi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

9.  Methadone-induced hypoglycemia.

Authors:  Andrew J Faskowitz; Vladimir N Kramskiy; Gavril W Pasternak
Journal:  Cell Mol Neurobiol       Date:  2013-03-07       Impact factor: 5.046

10.  Clinical Management of Pain in Rodents.

Authors:  Patricia L Foley; Lon V Kendall; Patricia V Turner
Journal:  Comp Med       Date:  2019-12-10       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.